A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

Biotech giant Biogen Inc (NASDAQ:BIIB) is scheduled to report fourth-quarter earnings on 12 February. The Wall Street ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Some two years into Leqembi’s launch, Eisai continues to go all-in on its Alzheimer’s disease-fighting antibody, which the ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...

In a significant move to bolster the UK's position in the global AI landscape, the UK government has announced £82.6 million ...

High levels of variability in cholesterol over time were linked to a significantly higher risk for dementia and cognitive ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

I’m really annoyed, on behalf of the journalist Charles Piller, about the release date of his book “ Doctored: Fraud, ...

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer's disease, ...